Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Study Supports Delay of Second Dose of AstraZeneca's COVID-19 Vaccine
Although designed for two doses, primary analysis of AstraZeneca and the University of Oxford’s Phase III data for its COVID-19 vaccine found it to have 76% efficacy after the first dose.
Bristol Myers psoriasis drug succeeds in late-stage study
(Reuters) - Bristol Myers Squib said on Tuesday its experimental oral drug for plaque psoriasis significantly reduced the extent and severity of the skin condition and was more effective than ...
Vaccine manufacturing greenhorn Bayer to make 160M doses of CureVac's COVID-19 shot
In its nearly 160-year history, Bayer has never produced vaccines for humans.
Bristol Myers Squibb Application for Zeposia® (ozanimod) for the Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by U.S. Food and Drug Administration
PRINCETON, NJ, USA I February 01, 2021Bristol Myers Squibb (NYSE.
Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa
BEDMINSTER, NJ, USA I February 01, 2021 IMatinas BioPharma Holdings, Inc.
Eli Lilly's COVID-19 antibody picks up $871M in Q4—and carries blockbuster hopes for 2021
Eli Lilly's COVID-19 antibody stole the show during the fourth quarter, and the company says there's more to come as the U.
Invasive candidiasis treatment rezafungin wins orphan drug status
Mundipharma and Cidara Therapeutics’ rezafungin has been granted an orphan drug designation from the European Commission for the treatment of invasive candidiasis (IC).
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
COVID-19 Vaccine AstraZeneca is now authorised across the EU.
Colchicine may have therapeutic potential against COVID-19
Against the sheer scale of morbidity and death due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the urgency of identifying drugs and other measures that reduce these adverse ou...
Anticoagulant drug heparin targets coronavirus spike protein and could be repurposed to treat COVID-19
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 vir...
AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials
AstraZeneca (AZ) and Daiichi Sankyo have posted new data from Phase I/II trials evaluating their respective antibody drug conjugates (ADCs) Enhertu (trastuzumab deruxtecan) and...
J&J vaccine adds to COVID-19 armoury with 66% global trial efficacy
(Reuters) - Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health offi...
253
254
255
256
257
258
259
260
261
